Home/Draupnir Bio/Andrew Hotchkiss
AH

Andrew Hotchkiss

Chief Executive Officer

Draupnir Bio

Draupnir Bio Pipeline

DrugIndicationPhase
Extracellular Protein Degrader PlatformUndisclosed (Multiple)Preclinical